Among the 489 cases with immunohistochemistry records of tumor tissues, 339 (69.39 %) cases were ER positive, 283 (57.87%) cases were PR positive, and 327 (66.87 %) cases were HER-2 positive. This evidence concerns the gene ERBB2 and neoplasm.